scispace - formally typeset
D

David Heber

Researcher at University of California, Los Angeles

Publications -  445
Citations -  32045

David Heber is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 90, co-authored 393 publications receiving 29672 citations. Previous affiliations of David Heber include Oklahoma State University Center for Health Sciences & University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice

TL;DR: The superior bioactivity of PJ compared to its purified polyphenols illustrated the multifactorial effects and chemical synergy of the action of multiple compounds compared to single purified active ingredients.
Journal ArticleDOI

Low-fat dietary pattern and risk of cardiovascular disease : The women's health initiative randomized controlled dietary modification trial

Barbara V. Howard, +48 more
- 08 Feb 2006 - 
TL;DR: A dietary intervention that reduced total fat intake and increased intakes of vegetables, fruits, and grains did not significantly reduce the risk of CHD, stroke, or CVD in postmenopausal women and achieved only modest effects on CVD risk factors, suggesting that more focused diet and lifestyle interventions may be needed to improve risk factors and reduce CVDrisk.
Journal ArticleDOI

Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial

TL;DR: Two-year treatment with orlistat plus diet significantly promotes weight loss, lessens weight regain, and improves some obesity-related disease risk factors.
Journal ArticleDOI

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

TL;DR: The combination of TGZ and ATRA synergistically and irreversibly inhibits growth and induces apoptosis of MCF7 breast cancer cells and the combination may provide a novel, nontoxic and selective therapy for human breast cancers.
Journal ArticleDOI

Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro.

TL;DR: The data provided by the current study and from other laboratories warrants further investigation into the chemopreventive and chemotherapeutic effects of berries using in vivo models.